title: Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.
authors.forename: Neeraj
authors.initials: N
authors.lastname: Dhaun
authors.forename: Neil R
authors.initials: NR
authors.lastname: Johnston
authors.forename: Jane
authors.initials: J
authors.lastname: Goddard
authors.forename: David J
authors.initials: DJ
authors.lastname: Webb
mesh_terms: D018592:Cross-Over Studies; D004311:Double-Blind Method; D065130:Endothelin A Receptor Antagonists; D006973:Hypertension / Q000097:blood* / Q000503:physiopathology; D033461:Hyperuricemia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D007555:Isoxazoles / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000503:physiopathology; D013876:Thiophenes / Q000627:therapeutic use*; D016896:Treatment Outcome; D014527:Uric Acid / Q000097:blood*
chemical_list: D065130:Endothelin A Receptor Antagonists; D007555:Isoxazoles; D013876:Thiophenes; D014527:Uric Acid; C106276:sitaxsentan